High prevalence of dyslipidemia and associated risk factors among rural Chinese adults

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Sun, Guo Zhe ^a   Li, Zhao ^a   Guo, Liang ^a   Zhou, Ying ^a   Yang, Hong Mei ^a   Sun, Ying Xian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Dyslipidemia; Prevalence; Risk factors; Rural China

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRINKING BEHAVIOR; DYSLIPIDEMIA; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OBESITY; PREVALENCE; RISK FACTOR; RURAL POPULATION; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; CHINA; DYSLIPIDEMIAS; MIDDLE AGED;

ADULT; AGE DISTRIBUTION; AGED; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION; TRIGLYCERIDES;

EID: 84976898433     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-189     Document Type: Article

References (30)

1. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997, 349: 1269-1276.
2. Risk factors for cardiovascular disease in the developing world: a multicentre collaborative study in the International Clinical Epidemiology Network (INCLEN). INCLEN Multicentre Collaborative Group. J Clin Epidemiol. 1992, 45: 841-847.
3. Jong-wook L: Global health improvement and WHO: shaping the future. Lancet. 2003, 362: 2083-2088.
4. Reddy KS, Yusuf S: Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998, 97: 596-601.
5. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y: Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in china, part i: morbidity and mortality monitoring. Circulation. 2001, 103: 462-468.
6. Blood pressure, cholesterol, and stroke in eastern Asia: Eastern stroke and coronary heart disease collaborative research group. Lancet. 1998, 352: 1801-1807.
7. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD: Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 2000, 284: 311-318.
8. Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001, 104: 2746-2753.
9. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002, 360: 7-22.
10. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R,: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet. 2005, 366: 1267-1278.
11. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ,: Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol. 2004, 44: 720-732.
12. Toth PP, Potter D, Ming EE: Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003-2006. J Clin Lipidol. 2012, 6: 325-330.
13. Zhao WH, Zhang J, Zhai Y, You Y, Man QQ, Wang CR, Li H, Li Y, Yang XG: Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed Environ Sci. 2007, 20: 329-335.
14. Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, Reynolds RF, Whelton PK, He J: Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study Of Cardiovascular Disease in Asia (InterAsia). Circulation. 2005, 112: 658-665.
15. Wu JY, Duan XY, Li L, Dai F, Li YY, Li XJ, Fan JG: Dyslipidemia in Shanghai, China. Prev Med. 2010, 51: 412-415.
16. Cai L, Zhang L, Liu A, Li S, Wang P: Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. J Atheroscler Thromb. 2012, 19: 159-168.
17. Wang S, Xu L, Jonas JB, You QS, Wang YX, Yang H: Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS One. 2011, 6: e17326-
18. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, O'Malley K, Jamieson M, Altman D, Bland M, Atkins N: The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens. 1990, 8: 607-619.
19. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, Barrett-Connor E: Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol. 2003, 158: 1161-1170.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart L, Blood Institute DE,: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report. JAMA. 2003, 289: 2560-2572.
21. Hypertension control: report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1996, 862: 1-83.
22. World Health Organ: Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser. 2003, 916: 1-8. 1-149, backcover
23. Bergman M: Inadequacies of absolute threshold levels for diagnosing prediabetes. Diabetes Metab Res Rev. 2010, 26: 3-6.
24. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497.
25. Zhang X, Sun Z, Zheng L, Li J, Liu S, Xu C, Li J, Zhao F, Hu D, Sun Y: Prevalence of dyslipidemia and associated factors among the hypertensive rural chinese population. Arch Med Res. 2007, 38: 432-439.
26. Fuentes R, Uusitalo T, Puska P, Tuomilehto J, Nissinen A: Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries: a review of population-based studies carried out from 1979 to 2002. Eur J Cardiovasc Prev Rehabil. 2003, 10: 411-419.
27. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M: Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine. 2008, 34: 36-51.
28. Wang B, Wei D, Wang C, Zhang J, Pan L, Ma M, Xue F, Wu Z, Shan G: Prevalence of dyslipidemia and associated factors in the Yi farmers and migrants of Southwestern China. Atherosclerosis. 2012, 223: 512-518.
29. Khader YS, Batieha A, El-Khateeb M, Al Omari M, Ajlouni K: Prevalence of dyslipidemia and its associated factors among Jordanian adults. J Clin Lipidol. 2010, 4: 53-58.
30. Houston MC, Basile J, Bestermann WH, Egan B, Lackland D, Hawkins RG, Moore MA, Reed J, Rogers P, Wise D, Ferrario CM: Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci. 2005, 329: 276-291.